Abstract
Asthma in adults is a clinical syndrome that is largely allergic in nature, which manifests reversible to partially reversible airway obstruction. Asthma is underdiagnosed and undertreated in the United States, especially in those who are >40 years of age or older. Despite the reduction in asthma mortality since 1996, morbidity and healthcare resource utilization associated with asthma continue to increase. Forty to sixty percent of asthma patients do not achieve asthma control, and the basics of asthma care are missing for large segments of the population, including African Americans, Native Indians, Hispanics, and Asians. The annual cost for asthma is nearly $15 billion with 80% of the direct costs directed at only 10–20% of asthmatic patients. The inability to bring about well-controlled asthma in every patient by applying the current NIH-NAEPP guidelines should draw attention to disease heterogeneity and the urgent need to reconsider old paradigms with new ideas.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- FEV1 :
-
Forced expiratory volume in the first second
- AOA:
-
Adult onset asthma
- LOA:
-
Late-onset asthma
- GERD:
-
Gastroesophageal reflux disease
- NAEPP-EPR3:
-
National Asthma Education and Prevention Program – Expert Panel Report 3
- COPD:
-
Chronic obstructive pulmonary disease
- CS:
-
Corticosteroid
- ICS:
-
Inhaled corticosteroid
- LABA:
-
Long-acting β-agonist
- SABA:
-
Short-acting β-agonist
- CDC:
-
Centers for disease control
- HRT:
-
Hormone replacement therapy
- CI:
-
Confidence interval
- NSAID:
-
Nonsteroidal anti-inflammatory drug
- COX:
-
Cyclooxygenase
- LT:
-
Leukotriene
- GOLD:
-
Global obstructive lung disease
- cys-LT:
-
Cysteinyl leukotriene
- BMI:
-
Body Mass Index
- RANTES:
-
Regulated upon activation normal T-cell expressed and secreted
- GWA:
-
Genome-wide association
- NO:
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- AHR:
-
Airway hyperresponsiveness
- FENO :
-
Fraction of exhaled nitric oxide
- EBC:
-
Exhaled breath condensate
- PEF:
-
Peak expiratory flow
- LTRA:
-
Leukotriene receptor antagonist
- PC20 :
-
The provocative concentration or dose of methacholine that causes a 20% decrease in baseline FEV1
- FDA:
-
Food and drug administration
- SARP:
-
Severe Asthma Research Program
- ACRN:
-
Asthma Clinical Research Network
- PPARγ:
-
Peroxisome proliferator-activated receptor-gamma
- PDE4:
-
Phosphodiesterase 4
- BDP:
-
Beclomethasonedipropionate
- FP:
-
Fluticasone propionate
- MDI:
-
Metered dose inhaler
- DPI:
-
Dry powder inhaler
- TNF:
-
Tumor necrosis factor
References
Anderson, G. Endotyping Asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372:1107–19.
Moore WC, Meyers D.A, Wenzel SE, et al. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315–323.
Martinez, FD. The Origins of Asthma and Chronic Obstructive Pulmonary Disease in Early Life. Proc Am Thorac Soc 2009;6:272–277.
Martin RJ, Szefler SJ, King TS, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007;119:73–80.
Braman, S. The Global Burden of Asthma. Chest 2006;130:4 S-12 S.
Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010;376:803–13.
Buffels J, Degryse J., Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: The DIDASCO Study. Chest 2004;125:1394–99.
Abramson M, Matheson M., Wharton C, et al. Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults. Respirology 2002;7(4):325–31.
Soriano JB, Davis KJ, Coleman B, et al. The Proportional Venn Diagram of Obstructive Lung Disease: Two Approximations From the United States and the United Kingdom. Chest 2003;124:474–481.
Bochenska-Marciniak M, Kupczyk M, Gorski P, et al. Prevalence of atopy and the diagnostic value of skin prick tests in asthmatics over the age of 60. J Allergy Clin Immunol 2001;107(2): A862.
Mediaty A, Neuber K. Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patients with atopic dermatitis. Immunity & Ageing 2005;2:9–14.
Huss K, Naumann PL, Mason PJ, et al. Asthma severity, atopic status, allergen exposure, and quality of life in elderly persons. Annals of Allergy, Asthma, & Immunonology 2001;86(5):524–530.
Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999;160:594–9.
Siroux V, Curt F., Oryszczyn MP, et al. Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol 2004;114:491–98.
Barr RG, Wentowski CC, Grodstein F, et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004;164:379–86.
Gakia E, Papatheodorou G., Ischakia E, et al. Leukotriene E4 in urine in patients with asthma and COPD – The effect of smoking habit. Respiratory Medicine 2007;101(4):826–832.
Mastronarde JG, Anthonisen NR., Castro M, et al. Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma: The American Lung Association Asthma Clinical Research Centers. N Engl J Med 2009;360(15):1487–99.
Gunnbjornsdottir MI, Omenaas E., Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004;24:116–21.
Beuther DA, Weiss ST, Sutherland ER. Obesity and Asthma. Am J Respir Crit Care Med 2006;174:112–119.
Hizawa N, Yamaguchi E, Konno S, et al. A functional polymorphism in the RANTES gene promotor is associated with the development of late-onset asthma. Am J Respir Crit Care Med 2002;166:686–690.
van Diemen CC, Postma DS, Vonk JM, et al. A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population. Am J Respir Crit Care Med 2005;172:329–333.
Raby BA, Van SK, Celedon JC, et al. CAMP Research Group. Paternal history of asthma and airway responsiveness in children with asthma. Am J Respir Crit Care Med 2005;172:552–558.
Melen E, Bruce S, Doekes G, et al. Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. Am J Respir Crit Care Med 2005;171:1089–1095.
Litonjua AA, Lasky-Su J, Schneiter K, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688–694.
Sohn MH, Lee JH, Kim KW, et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009;179:449–456.
Smit LA, Siroux V, Bouzigon E, et al. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 2009;179:363–368.
Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41:342–347.
Prefontaine D, Lajoie-Kadoch S, Foley S, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009;183:5094–5103.
Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial. Lancet 2004;364:1505–12.
Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113:101–8.
Schneider A, Tilemann L, Schermer T, et al. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement – results of a prospective diagnostic study. Respiratory Research 2009;10:15–25.
Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007;176:238–242.
National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Full Report. Bethesda, MD: National Institutes of Health, US Dept of Health and Human Services, National Heart, Lung, and Blood Institute., 2007 (http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.).
Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma. N Engl J Med 2010;363:1715–26.
Szefler SJ, Martin RJ, King TS, et al., Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109(3):410–8.
Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006;129:246–256.
Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular β2 -agonist use in patients with asthma. Ann Intern Med 2004;140:802–13.
Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583–93.
Nelson HS, W.S., Bleecker ER, et al. and the SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol. Chest 2006;129:15–26.
Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108(2):184–190.
Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58(3):204–210.
Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003;327(7420):891–896.
Sims EJ, Jackson CM, Lipworth BJ. Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype. Br J Clin Pharmacol 2003;56:104–11.
Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973–984.
Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985–993.
Denning DW, O’Driscoll B, Powell G, et al. Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization: The Fungal Asthma Sensitization Trial (FAST) Study. Am J Respir Crit Care Med 2009;179:11–18.
Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma. Am J Respir Crit Care Med 2008;177:148–155.
Sutherland ER, King TS, Icitovic N, et al. for the National Heart, Lung and Blood Institute’s Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010;126:747–53.
Daoud A, Gloria CJ, Taningco G, et al. Minocycline treatment results in reduced oral steroid requirements in adult asthma. Allergy Asthma Proc 2008;29(3):286–94.
Castro M, Rubin AS, Laviolette M, et al. AIR2 Trial Study Group. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181(2):116–24.
Miller JD, Cox G, Vincic L, et al. A Prospective Feasibility Study of Bronchial Thermoplasty in the Human Airway. Chest 2005;127:1999–2006.
Cox G, Thomson NC, Rubin AS, et al. AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007;356(13):1327–37.
Pavord ID, Cox G, Thomson NC, et al. RISA Trial Study Group. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176(12):1185–91.
Cox MB, Laviolette M, Rubin A, et al. 5-year Safety of Bronchial Thermoplasty Demonstrated in Patients with Moderate to Severe Asthma: Asthma Intervention Research (AIR) Trial. Am J Respir Crit Care Med 2010;181:A6839.
Barnes, P. New therapies for asthma: is there any progress? Trends in Pharmacological Sciences 2010;31(7):335–343.
Sutherland ER, Goleva E, Jackson LP, et al. Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma. Am J Respir Crit Care Med 2010;181:699–704.
Grootendorst DC, Gauw S, Verhoosel RM, et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax 2007;62:1081–1087.
Lu S, Liu N, Dass SB, et al. Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma. Respiratory Medicine 2009;103:342–347.
Liao JK, LaufsU. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89–118.
Alexeeff SE, Litonjua A, Sparrow D, et al. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007;176:742–747.
Blamoun AI, Batty G, DeBari VA, et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 2008;62(9):1373–8.
Soyseth V, Brekke P, Smith P, et al. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007;29(2):279–83.
Hothersall EJ, Chaudhuri R, McSharry C, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008;63:1070–1075.
Menzies D, Nair A, Meldrum KT, et al. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007;119:328–335.
Cowan DC, Cowan JO, Palmay R, et al. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010;65:891–896.
Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, et al. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010;126:754–62.
Drazen JM, Boccuzzi S, Wogen J, et al. Adherence to prescribed treatment for asthma. Am J Respir Crit Care Med 2000;161:A402.
Sundberg R, Toren K, Franklin KA, et al. Asthma in men and women: Treatment adherence, anxiety, and quality of sleep. Respiratory Medicine 2010;104:337–344.
Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143–178.
Wenzel SE, Fahy JV, Irvin C, et al. Proceedings of the ATS workshop on refractory asthma current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341–2351.
Barnes P. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 2009;39:1145–1151.
Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001–1008.
Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006;11:54–61.
Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388–395.
Melgert BN, Ray A, Hylkema MN, et al. Are there reasons why adult asthma is more common in females? Curr Allergy Asthma Rep 2007;7:143–150.
Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780–793.
Schleimer RP, Kato A, Kern R, et al. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007;120:1279–1284.
Sciurba F. Physiologic similarities and differences between COPD and asthma. Chest 2004;126:117S–124S.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Zeki, A.A., Kenyon, N.J., Yoneda, K., Louie, S. (2012). The Adult Asthmatic. In: Gershwin, M., Albertson, T. (eds) Bronchial Asthma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6836-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6836-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6835-7
Online ISBN: 978-1-4419-6836-4
eBook Packages: MedicineMedicine (R0)